MedPath

Correlation Between Glycated Hemoglobin and Mean Plasma Glucose in Hemodialysis Patients

Completed
Conditions
ESRD
Registration Number
NCT01634035
Lead Sponsor
Northwell Health
Brief Summary

The investigators are studying the correlation between Hba1c and the mean plasma glucose in diabetic hemodialysis patients.We are reviewing if HbA1c is a good clinical tool to assess glycemic control over a 3 months duration in hemodialysis patients

Detailed Description

The Hb turnover in hemodialysis population is higher than the general population leading to a general believe that HbA1c tend to underestimate mean plasma glucose.

The investigators are trying to define the correlation between mean plasma glucose and HbA1c in the hemodialysis population and trying to study the factors that could affect this correlation (dose of erythropoetin, ret count..) We are trying to see if HbA1c is a better tool to assess glycemic control over 1 month than glycemic control over 3 month.

This clinicaly will translate in obtaining HbA1c more frequently in hemodialysis patients to assess their glycemic control.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
159
Inclusion Criteria
  • Age>18
  • Hemodialysis and diabetic
  • Lab data are available for more than 6 months
Exclusion Criteria
  • Lab data not available

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Measure levels of plasma blood glucose and HbA1c6 month intervals
Secondary Outcome Measures
NameTimeMethod
Measure ferritin, erythropoetin dose, reticulocytes count6 month intervals

Trial Locations

Locations (1)

Staten Island University Hospital

🇺🇸

Staten Island, New York, United States

© Copyright 2025. All Rights Reserved by MedPath